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Hodgkin-like ATLL is a rare variant of adult T-cell leukemia/lymphoma (ATLL), a disease
caused by human T-cell lymphotropic virus type-1 (HTLV-1). At admission, a 46-year-old
female presented with lymphadenomegaly, lymphocytosis, slight elevation of LDH blood
level, and acid-alcohol resistant bacilli in sputum and was being treated for pulmonary
tuberculosis (Tb). She had lymphocytosis in the previous 20 months. Serology for HTLV-
1  was positive. Lymph node was inﬁltrated by medium-sized lymphocytes with scattered
Hodgkin and Reed-Sternberg-like cells CD30+, CS1-4+, and CD79a+. Background cells were
CD4+  and CD25+. A clinical diagnosis of favorable chronic ATLL was given. She was treated
with chemotherapy but later progressed to acute ATLL and ultimately died. Hodgkin-like
ATLL should be considered in the histological differential diagnosis with Hodgkin lymphoma
since  treatment and prognosis of these diseases are distinct. It is also important to searchfor  HTLV-1 infection in patients with unexplained prolonged lymphocytosis.
©  2016 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an
open  access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).ntroduction
dult T-cell leukemia/lymphoma (ATLL) is a malignant tumor
f mature T-cells caused by the human T-cell lymphotropic
irus type-1 (HTLV-1), which responds poorly to chemother-
py. It is classiﬁed in four clinical types: smoldering, chronic,Please cite this article in press as: Bittencourt AL, et al. Prolonged lym
leukemia/lymphoma. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
ymphomatous, and acute. The chronic type is also subdivided
nto favorable and unfavorable types, based on serum levels of
rea, lactate dehydrogenase (LDH), and albumin.1
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413-8670/© 2016 Sociedade Brasileira de Infectologia. Published by E
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)Ohshima et al. (1991)2 in Japan, described four cases of
ATLL with Hodgkin and Reed–Sternberg (HRS)-like cells in
lymph nodes. Later on, the same group published 18 cases
of early ATLL with HRS-like cells, and demonstrated that
these cells were reactive and not infected by HTLV-1.3 It
was also shown that they were very frequently infected
by Epstein–Barr virus (EBV).3 In western countries, cases ofphocytosis as the ﬁrst manifestation of Hodgkin-like adult T-cell
d.2016.09.005
Hodgkin-like-ATLL have been rarely reported.4,5 Hodgkin-like
T-cell lymphomas not associated with HTLV-1 have also been
reported.6–9
lsevier Editora Ltda. This is an open access article under the CC
.
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Here we  report a case of Hodgkin-like ATLL in which lym-
phocytosis was the ﬁrst manifestation.
Case  report
A 46-year-old black female patient was referred to the Hema-
tological Unit of the University Hospital Prof. Edgard Santos,
in Bahia, Brazil in January 2012 with conﬁrmed HTLV-1 infec-
tion (ELISA positive conﬁrmed by Western blot) and a history
of cervical lymphadenomegaly in the previous month. She
had had a diagnosis of pulmonary tuberculosis three months
before in another center and was on rifampicin and isoniazid.
Her blood tests taken in the previous 20 months showed lym-
phocytosis varying from 10,000 to 13,700 lymphocytes/mm3.
Physical examination revealed cervical and retroauricular
lymphadenomegaly. No skin lesions were observed. Blood
examination showed leukocytosis with mild lymphocytosis
(5940 lymphocytes/mm3). The blood levels of calcium, urea,
and albumin were within the normal limits but the LDH
was slightly elevated. Flow cytometry of peripheral blood
revealed an expression of CD3, CD4, CD5, TCR and CD2Please cite this article in press as: Bittencourt AL, et al. Prolonged lym
leukemia/lymphoma. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
with co-expression of CD25. The lymphoid cells were nega-
tive for CD7, CD8, TCR, and for NK cell and B-cell markers.
Serology for HIV was negative. Cervical and thoracic com-
puted tomography (CT) showed cervical and thoracic enlarged
Fig. 1 – (A) Hodgkin and Reed Sternberg-like cells in a backgroun
inset shows a RS-like cell with prominent nucleoli, 560×. (B) Back
and Reed–Sternberg-like cells, 400×; in inset a CD20+ cell (800×) 6;x x x(x x):xxx–xxx
lymph nodes and inﬁltration in the left lung; abdominal CT
was normal. A lymph node biopsy was performed and a
diagnosis of Hodgkin-like ATLL was given, clinically corre-
sponding to a favorable chronic ATLL. It was decided that the
treatment for ATLL should begin after Tb control, consider-
ing the high toxicity of the combined therapy and the fact
that favorable chronic ATLL constitutes an indolent form of
ATLL.1
ATLL treatment was initiated six months after admis-
sion with zidovudine and interferon- but due to important
side-effects the drugs were discontinued and the patient
began to be treated with six cycles of standard CHOP
(cyclophosphamide, doxorubicin, vincristine, and prednisone)
with partial response. After 14 months of Tb treatment, she
was considered cured with no acid-alcohol resistant bacilli
in sputum smears and negative culture for Mycobacterium
tuberculosis. The lymphocytosis reappeared after the end of
chemotherapy and persisted until September 2013 varying
from 4600 to 8000 lymphocytes/mm3. At this time, CT revealed
enlarged cervical, thoracic and abdominal lymph nodes. Eleva-
tion of LDH, 2.5 times the upper normal limit, bilateral pleural
effusion, slight peritoneal effusion and paresthesia and uni-
lateral palpebral ptosis were also observed. She received two
more  salvage regimen of chemotherapy with partial responsephocytosis as the ﬁrst manifestation of Hodgkin-like adult T-cell
d.2016.09.005
and died at home four months later. Pathologic ﬁndings – The
lymph node exhibited diffuse inﬁltration of medium-sized
atypical lymphocytes. Scattered in this background, HRS-like
d of small-to medium-sized lymphocytes, H&E stain, 400×;
ground with CD25+ lymphocytes, 125×. (C) CD30+ Hodgkin
. (D) CS1-4+ Hodgkin and RS-like cells, 800×.
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ells were seen, isolated or in small clusters (Fig. 1A). The
edium-sized lymphocytes expressed CD3, CD4, CD5, CD25
Fig. 1B), CD45RO (UCHL-1) and were CD8 negative. A marked
eduction of CD7 expression was observed. The HRS-like cells
ere positive for CD30 (Fig. 1C), CS1-4 (Fig. 1D), CD79a, and
ocally for Bcl6 and CD20. The proliferative index as deter-
ined by Ki-67 immunostaining was 50%, especially in the
iant cells. Both cell types were negative for CD10, CD15, CD21,
D23, and PD1.
iscussion
he ﬁrst manifestation of disease was lymphocytosis which
ersisted until after initiating chemotherapy but reappeared
ven before completion of this therapy. These data indicate
hat the lymphocytosis was related to ATLL and had appeared
efore the other manifestations, probably developing a few
onths before Tb. It is important to consider that the presence
f persistent lymphocytosis in an HTLV-1 carrier may some-
imes represent an early neoplastic phase of ATLL, as occurred
n the current case.10,11 The case progressed from favorable
hronic to acute ATLL, presenting neurological manifesta-
ions, elevation of the LDH level and pleural and peritoneal
ffusions.
The pathological differential diagnosis between Hodgkin-
ike ATLL and classical Hodgkin lymphoma (HL) can be made
y careful scrutiny of the background lymphoid cells. These
ells are generally atypical in Hodgkin-like ATLL whereas they
ave normal morphology in classic HL. In the present case the
ackground cells were atypical and showed CD3, CD4, CD5,
nd CD25 phenotypes with a marked reduction of CD7 posi-
ivity, as observed in ATLL1 and were negative for CD10 and
D1 enabling a differential diagnosis with angioimmunoblas-
ic lymphoma, a disease that may also present HRS-like cells.6
Immunophenotypically, the HRS cells of classic HL are
D30+ and CD15+, can express the B-cell-associated marker
D20, and generally fail to express CD45 or T-cell associated
ntigens.8 The same is observed in the HRS cells of T-cell
odgkin-like lymphomas.3–5,7 In the present case the HRS cells
ere CD30+, CD20+, CD79a+ but CD15 was negative as may
ccur in these lymphomas.3,4
The infection by EBV was detected by immunohistochem-
stry through the LMP-1 protein positivity as seen in other
ases of Hodgkin-like ATLL.3,5 In EBV positive T-cell Hodgkin-
ike lymphomas, the HRS-like cells are believed to represent
n expansion of EBV-transformed B cells, clonally unrelated
o the lymphoma.8 Similarly, the HRS-like cells occurring in
odgkin-like ATLL are reactive and not infected by HTLV-1.3
HTLV-1 infection causes immune system dysregulation
ith spontaneous lymphoproliferation and increased T-cell
ctivation leading to production of high amounts of several
ytokines.12 Due to this dysregulation HTLV-1 infected individ-
als are more  prone to develop Tb as well as other infectious
iseases. The severity of Tb observed in individuals with HTLV-
 infection is considered to be due to enhancement of Th1Please cite this article in press as: Bittencourt AL, et al. Prolonged lym
leukemia/lymphoma. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
nﬂammatory response, rather than to their decreased ability
o control bacterial proliferation.13
In a previous study we showed a median survival time of
hronic ATLL to be around 18 months.14 In one study, the use;x  x x(x x):xxx–xxx 3
of antiviral therapy in chronic ATLL has resulted in a 5-year
survival of 100% of the cases.15 Unfortunately, this patient
could not be treated with antiviral drugs because of marked
side-effects and had a survival of 24 months.
It is of fundamental importance for pathologists to recog-
nize Hodgkin-like ATLL in order not to misdiagnose this entity
with Hodgkin lymphoma since the treatment and prognosis of
these diseases are quite distinct. Moreover, in endemic areas
it is important to search for HTLV-1 infection in patients with
an unexplained prolonged lymphocytosis that may represent
the ﬁrst manifestation of ATLL.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
Acknowledgements
This study was supported by Conselho Nacional de Pesquisa
(CNPq) and Fundac¸ão de Apoio à Pesquisa do Estado da Bahia
(FAPESB).
 e  f  e  r  e  n  c  e  s
1. Tsukasaki K, Hermine O, Bazarbachi A, et al. Deﬁnition,
prognostic factors, treatment, and response criteria of adult
T-cell leukemia lymphoma: a proposal from an international
consensus meeting. J Clin Oncol. 2009;27:453–9.
2. Ohshima K, Kikuchi M, Yoshida Y, et al. Lymph nodes in
incipient adult T-cell leukemia-lymphoma with Hodgkin’s
disease-like histologic features. Cancer. 1991;67:1622–8.
3. Ohshima K, Suzumiya J, Kato A, et al. Clonal HTLV-I-infected
CD4+ T-lymphocytes and non-clonal non-HTLV-I-infected
giant cells in incipient ATLL with Hodgkin-like histologic
features. Int J Cancer. 1997;72:592–8.
4. Yagi T, Ishikawa J, Aono N, et al. Epstein–Barr virus-associated
post-transplant lymphoproliferative disorders after
allogeneic peripheral blood stem cell transplantation for
Hodgkin-like adult T-cell leukemia/lymphoma. Int J Hematol.
2012;95:214–6.
5. Venkataraman G, Berkowitz J, Morris JC, et al. Adult T-cell
leukemia/lymphoma with Epstein–Barr virus-positive
Hodgkin-like cells. Hum Pathol. 2011;42:1042–6.
6. Nicolae A, Pittaluga S, Venkataraman G, et al. Peripheral T-cell
lymphomas of follicular T-helper cell derivation with
Hodgkin/Reed-Sternberg cells of B-cell lineage: both
EBV-positive and EBV-negative variants exist. Am J Surg
Pathol. 2013;37:816–26.
7. Quintanilla-Martinez L, Fend F, Moguel LR, et al. Peripheral
T-cell lymphoma with Reed–Sternberg-like cells of B-cell
phenotype and genotype associated with Epstein–Barr virus
infection. Am J Surg Pathol. 1999;23:1233–40.
8. Barry TS, Jaffe ES, Sorbara L, et al. Peripheral T-cell
lymphomas expressing CD30 and CD15. Am J Surg Pathol.
2003;27:1513–22.
9. Eberle FC, Song JY, Xi L, et al. Nodal involvement by cutaneous
CD30-positive T-cell lymphoma mimicking classical Hodgkin
lymphoma. Am J Surg Pathol. 2012;36:716–25.
0. Ikeda S, Momita S, Kinoshita K, et al. Clinical course ofphocytosis as the ﬁrst manifestation of Hodgkin-like adult T-cell
d.2016.09.005
human T-lymphotropic virus type I carriers with molecularly
detectable monoclonal proliferation of T lymphocytes:
deﬁning a low- and high-risk population. Blood.
1993;82:2017–24.
ARTICLE IN PRESSBJID-649; No. of Pages 4
 . 2 0 1
1
1
1
1
15. Bazarbachi A, Plumelle Y, Ramos CJ, et al. Meta-analysis on4  b r a z j i n f e c t d i s
1. Bittencourt AL, Oliveira PD, Bittencourt VG, et al. Adult T-cell
leukemia/lymphoma triggered by adalimumab. J Clin Virol.
2013;58:494–6.
2. Carvalho EM, Bacellar O, Porto AF, et al. Cytokine proﬁle and
immunomodulation in asymptomatic human T-lymphotropicPlease cite this article in press as: Bittencourt AL, et al. Prolonged lym
leukemia/lymphoma. Braz J Infect Dis. 2016. http://dx.doi.org/10.1016/j.bji
virus type 1-infected blood donors. J AIDS. 2001;27:1–6.
3. Bastos de LM, Santos SB, Souza A, et al. Inﬂuence of HTLV-1
on the clinical, microbiologic and immunologic presentation
of tuberculosis. BMC Infect Dis. 2012;12:199–226. 6;x x x(x x):xxx–xxx
4. Bittencourt AL, Vieira GM, Brites CR, et al. Adult T-cell
leukemia/lymphoma in Bahia, Brazil: analysis of prognostic
factors in a group of 70 patients. Am J Clin Pathol.
2007;128:875–82.phocytosis as the ﬁrst manifestation of Hodgkin-like adult T-cell
d.2016.09.005
the  use of zidovudine and interferon-alfa in adult T-cell
leukemia/lymphoma showing improved survival in the
leukemic subtypes. J Clin Oncol. 2010;28:4177–83.
